Garrido-Ramos MA. Satellite DNA: an evolving topic. Genes. 2017;8(9):230.
Article
PubMed Central
CAS
Google Scholar
Lower SS, McGurk MP, Clark AG, et al. Satellite DNA evolution: old ideas, new approaches. Curr Opin Genet Dev. 2018;49:70–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bonneville R, Krook MA, Chen HZ, et al. Detection of microsatellite instability biomarkers via next-generation sequencing. Methods Mol Biol. 2020;2055:119–32.
Article
PubMed
PubMed Central
Google Scholar
Nikanjam M, Arguello D, Gatalica Z, et al. Relationship between protein biomarkers of chemotherapy response and microsatellite status, tumor mutational burden, and PD-L1 expression in cancer patients. Int J Cancer. 2019. https://doi.org/10.1002/ijc.32661.
Article
PubMed
PubMed Central
Google Scholar
Cohen R, Hain E, Buhard O, et al. Association of primary resistance to immune checkpoint inhibitors in metastatic colorectal cancer with misdiagnosis of microsatellite instability or mismatch repair deficiency status. JAMA Oncol. 2018. https://doi.org/10.1001/jamaoncol.2018.4942.
Article
PubMed
PubMed Central
Google Scholar
Hempelmann JA, Lockwood CM, Konnick EQ, et al. Microsatellite instability in prostate cancer by PCR or next-generation sequencing. J Immunother Cancer. 2018;6(1):29.
Article
PubMed
PubMed Central
Google Scholar
Cheng DT, Prasad M, Chekaluk Y, et al. Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing. BMC Med Genomics. 2017;10(1):33.
Article
PubMed
PubMed Central
CAS
Google Scholar
First Comprehensive Companion Diagnostic OK’d. Cancer Discov 2018, 8(3):OF4.
Suraweera N, Duval A, Reperant M, et al. Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. Gastroenterology. 2002;123(6):1804–11.
Article
CAS
PubMed
Google Scholar
Berg KD, Glaser CL, Thompson RE, et al. Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction. J Mol Diagn. 2000;2(1):20–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Arulananda S, Thapa B, Walkiewicz M, et al. Mismatch repair protein defects and microsatellite instability in malignant pleural mesothelioma. J Thorac Oncol. 2018;13(10):1588–94.
Article
PubMed
Google Scholar
Cheah PL, Li J, Looi LM, et al. Screening for microsatellite instability in colorectal carcinoma: practical utility of immunohistochemistry and PCR with fragment analysis in a diagnostic histopathology setting. Malays J Pathol. 2019;41(2):91–100.
CAS
PubMed
Google Scholar
Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58(22):5248–57.
CAS
PubMed
Google Scholar
Bacher JW, Flanagan LA, Smalley RL, et al. Development of a fluorescent multiplex assay for detection of MSI-High tumors. Dis Markers. 2004;20(4–5):237–50.
Article
PubMed
PubMed Central
Google Scholar
Zhu X, Chen MS, Tian LW, et al. Single nucleotide polymorphism of rs430397 in the fifth intron of GRP78 gene and clinical relevance of primary hepatocellular carcinoma in Han Chinese: risk and prognosis. Int J Cancer. 2009;125(6):1352–7.
Article
CAS
PubMed
Google Scholar
Berardinelli GN, Scapulatempo-Neto C, Duraes R, et al. Advantage of HSP110 (T17) marker inclusion for microsatellite instability (MSI) detection in colorectal cancer patients. Oncotarget. 2018;9(47):28691–701.
Article
PubMed
PubMed Central
Google Scholar
Waalkes A, Smith N, Penewit K, et al. Accurate pan-cancer molecular diagnosis of microsatellite instability by single-molecule molecular inversion probe capture and high-throughput sequencing. Clin Chem. 2018;64(6):950–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu J, Li D, Luo H, et al. Circular RNAs: the star molecules in cancer. Mol Aspects Med. 2019;70:141–52.
Article
CAS
PubMed
Google Scholar
Kautto EA, Bonneville R, Miya J, et al. Performance evaluation for rapid detection of pan-cancer microsatellite instability with MANTIS. Oncotarget. 2017;8(5):7452–63.
Article
PubMed
Google Scholar
Pietrantonio F, Miceli R, Raimondi A, et al. Individual patient data meta-analysis of the value of microsatellite instability as a biomarker in Gastric cancer. J Clin Oncol. 2019;37:3392–400.
Article
PubMed
Google Scholar
Hughes CR, Queller DC. Detection of highly polymorphic microsatellite loci in a species with little allozyme polymorphism. Mol Ecol. 1993;2(3):131–7.
Article
CAS
PubMed
Google Scholar
Lai Y, Sun F. The relationship between microsatellite slippage mutation rate and the number of repeat units. Mol Biol Evol. 2003;20(12):2123–31.
Article
CAS
PubMed
Google Scholar
Tang X, Huang Y, Lei J, et al. The single-cell sequencing: new developments and medical applications. Cell Biosci. 2019;9:53.
Article
PubMed
PubMed Central
Google Scholar
Cortes-Ciriano I, Lee S, Park WY, et al. A molecular portrait of microsatellite instability across multiple cancers. Nat Commun. 2017;8:15180.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tanne A, Muniz LR, Puzio-Kuter A, et al. Distinguishing the immunostimulatory properties of noncoding RNAs expressed in cancer cells. Proc Natl Acad Sci USA. 2015;112(49):15154–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhu X, Luo H, Xu Y. Transcriptome analysis reveals an important candidate gene involved in both nodal metastasis and prognosis in lung adenocarcinoma. Cell Biosci. 2019;9:92.
Article
PubMed
PubMed Central
CAS
Google Scholar
Patil DT, Bronner MP, Portier BP, et al. A five-marker panel in a multiplex PCR accurately detects microsatellite instability-high colorectal tumors without control DNA. Diagn Mol Pathol. 2012;21(3):127–33.
Article
CAS
PubMed
Google Scholar
Hause RJ, Pritchard CC, Shendure J, et al. Corrigendum: classification and characterization of microsatellite instability across 18 cancer types. Nat Med. 2018;24(4):525.
Article
CAS
PubMed
Google Scholar
Chan EM, Shibue T, McFarland JM, et al. WRN helicase is a synthetic lethal target in microsatellite unstable cancers. Nature. 2019;568(7753):551–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Latham A, Srinivasan P, Kemel Y, et al. Microsatellite instability is associated with the presence of lynch syndrome pan-cancer. J Clin Oncol. 2018;37(4):286.
Article
PubMed
PubMed Central
Google Scholar
Bouzourene H, Hutter P, Losi L, et al. Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation. Fam Cancer. 2010;9(2):167–72.
Article
CAS
PubMed
Google Scholar
Guarinos C, Castillejo A, Barbera VM, et al. EPCAM germ line deletions as causes of Lynch syndrome in Spanish patients. J Mol Diagn. 2010;12(6):765–70.
Article
CAS
PubMed
PubMed Central
Google Scholar
Thibodeau SN, French AJ, Cunningham JM, et al. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res. 1998;58(8):1713–8.
CAS
PubMed
Google Scholar
Cosgrove CM, Tritchler DL, Cohn DE, et al. An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer. Gynecol Oncol. 2018;148(1):174–80.
Article
CAS
PubMed
Google Scholar
Dabir PD, Bruggeling CE, van der Post RS, et al. Microsatellite instability screening in colorectal adenomas to detect Lynch syndrome patients?. Eur J Hum Genet: A systematic review and meta-analysis; 2019.
Google Scholar
Saeterdal I, Bjorheim J, Lislerud K, et al. Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer. Proc Natl Acad Sci USA. 2001;98(23):13255–60.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nouri Nojadeh J, Hashemzadeh S, Samadi Kafil H, et al. Evaluation of microsatellite instability in tumor and tumor marginal samples of sporadic colorectal cancer using mononucleotide markers. EXCLI J. 2018;17:945–51.
PubMed
PubMed Central
Google Scholar
Morandi L, de Biase D, Visani M, et al. T([20]) repeat in the 3′-untranslated region of the MT1X gene: a marker with high sensitivity and specificity to detect microsatellite instability in colorectal cancer. Int J Colorectal Dis. 2012;27(5):647–56.
Article
PubMed
Google Scholar
Fujiyoshi K, Yamamoto G, Takahashi A, et al. High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases. Oncol Rep. 2017;37(2):785–92.
Article
CAS
PubMed
Google Scholar
Goldstein J, Tran B, Ensor J, et al. Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H). Ann Oncol. 2014;25(5):1032–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Carr PR, Alwers E, Bienert S, et al. Lifestyle factors and risk of sporadic colorectal cancer by microsatellite instability status: a systematic review and meta-analyses. Ann Oncol. 2018;29(4):825–34.
Article
CAS
PubMed
Google Scholar
Hasan S, Renz P, Wegner RE, et al. Microsatellite instability (MSI) as an independent predictor of pathologic complete response (PCR) in locally advanced rectal cancer: a National Cancer Database (NCDB) Analysis. Ann Surg. 2018. https://doi.org/10.1097/SLA.0000000000003051.
Article
PubMed
Google Scholar
Srdjan M, Jadranka A, Ivan D, et al. Microsatellite instability & survival in patients with stage II/III colorectal carcinoma. Indian J Med Res. 2016;143(Supplement):S104–11.
Article
PubMed
PubMed Central
Google Scholar
Arakawa K, Hata K, Kawai K, et al. Predictors for high microsatellite instability in patients with colorectal cancer fulfilling the revised bethesda guidelines. Anticancer Res. 2018;38(8):4871–6.
Article
PubMed
Google Scholar
Choi YY, Noh SH, Cheong JH. Molecular dimensions of gastric cancer: translational and clinical perspectives. J Pathol Transl Med. 2016;50(1):1–9.
Article
PubMed
Google Scholar
Bae YS, Kim H, Noh SH, et al. Usefulness of Immunohistochemistry for microsatellite instability screening in gastric cancer. Gut Liver. 2015;9(5):629–35.
Article
CAS
PubMed
PubMed Central
Google Scholar
Imamura Y, Watanabe M, Toihata T, et al. Recent incidence trend of surgically resected esophagogastric junction adenocarcinoma and microsatellite instability status in Japanese Patients. Digestion. 2019;99(1):6–13.
Article
CAS
PubMed
Google Scholar
Smyth EC, Wotherspoon A, Peckitt C, et al. Mismatch repair deficiency, microsatellite instability, and survival: an exploratory analysis of the medical research council adjuvant gastric infusional chemotherapy (MAGIC) trial. JAMA Oncol. 2017;3(9):1197–203.
Article
PubMed
Google Scholar
Pietrantonio F, Raimondi A, Choi YY, et al. MSI-GC-01: individual patient data (IPD) meta-analysis of microsatellite instability (MSI) and gastric cancer (GC) from four randomized clinical trials (RCTs). J Clin Oncol. 2019;37(4_suppl):66.
Article
Google Scholar
Marrelli D, Polom K, Pascale V, et al. Strong prognostic value of microsatellite instability in intestinal type non-cardia gastric cancer. Ann Surg Oncol. 2016;23(3):943–50.
Article
PubMed
Google Scholar
Ozer E, Yuksel E, Kizildag S, et al. Microsatellite instability in early-onset breast cancer. Pathol Res Pract. 2002;198(8):525–30.
Article
CAS
PubMed
Google Scholar
Fu Q, Yao GY, Tang XL, et al. Microsatellite instability and allele-specific chromosome 3p deletion in breast cancer and precancerous lesions. Zhonghua Zhong Liu Za Zhi. 2007;29(1):34–40.
CAS
PubMed
Google Scholar
Zhu Q, Pao GM, Huynh AM, et al. BRCA1 tumour suppression occurs via heterochromatin-mediated silencing. Nature. 2011;477(7363):179–84.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fraune C, Simon R, Hoflmayer D, et al. High homogeneity of mismatch repair deficiency in advanced prostate cancer. Virchows Arch. 2019. https://doi.org/10.1007/s00428-019-02701-x.
Article
PubMed
Google Scholar
Abida W, Cheng ML, Armenia J, et al. Analysis of the prevalence of microsatellite instability in prostate cancer and response to immune checkpoint blockade. JAMA Oncol. 2018;5:471–8.
Article
PubMed Central
Google Scholar
Goeppert B, Roessler S, Renner M, et al. Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma. Br J Cancer. 2019;120(1):109–14.
Article
CAS
PubMed
Google Scholar
Walker CJ, Eisfeld AK, Genutis LK, et al. No evidence for microsatellite instability in acute myeloid leukemia. Leukemia. 2017;31(6):1474–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Patel TN, Chakraborty M, Bhattacharya P. Microsatellite instability in chronic myeloid leukemia using D17S261 and D3S643 markers: a pilot study in Gujarat population. Indian J Cancer. 2017;54(2):426–9.
Article
CAS
PubMed
Google Scholar
Giedl J, Schneckenpointner R, Filbeck T, et al. Low frequency of HNPCC-associated microsatellite instability and aberrant MMR protein expression in early-onset bladder cancer. Am J Clin Pathol. 2014;142(5):634–9.
Article
CAS
PubMed
Google Scholar
Skeldon SC, Semotiuk K, Aronson M, et al. Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer. Eur Urol. 2013;63(2):379–85.
Article
CAS
PubMed
Google Scholar
Zekri AN, Khaled HM, Mohammed MB, et al. Microsatellite instability profiling in Egyptian bladder cancer patients: a pilot study. Curr Probl Cancer. 2019;43(6):100472.
Article
PubMed
Google Scholar
Wadhwa N, Mathew BB, Tandon S, et al. Assessment of microsatellite instability for screening bladder cancer in high-risk population. J Cancer Res Ther. 2018;14(5):916–20.
Article
CAS
PubMed
Google Scholar
Howitt BE, Strickland KC, Sholl LM, et al. Clear cell ovarian cancers with microsatellite instability: a unique subset of ovarian cancers with increased tumor-infiltrating lymphocytes and PD-1/PD-L1 expression. Oncoimmunology. 2017;6(2):e1277308.
Article
PubMed
PubMed Central
CAS
Google Scholar
Takeda T, Banno K, Yanokura M, et al. Synchronous endometrial and ovarian cancer in Lynch syndrome with a MSH2 germline mutation: a case report. Mol Clin Oncol. 2018;9(5):479–84.
PubMed
PubMed Central
Google Scholar
Howitt BE, Shukla SA, Sholl LM, et al. Association of polymerase e-mutated and microsatellite-instable endometrial cancers with neoantigen load, number of tumor-infiltrating lymphocytes, and expression of PD-1 and PD-L1. JAMA Oncol. 2015;1(9):1319–23.
Article
PubMed
Google Scholar
Llosa NJ, Luber B, Tam AJ, et al. Intratumoral adaptive immunosuppression and type 17 immunity in mismatch repair proficient colorectal tumors. Clin Cancer Res. 2019;25(17):5250–9.
Article
PubMed
PubMed Central
Google Scholar
Hussein YR, Soslow RA. Molecular insights into the classification of high-grade endometrial carcinoma. Pathology. 2018;50(2):151–61.
Article
CAS
PubMed
Google Scholar
Bilbao C, Lara PC, Ramirez R, et al. Microsatellite instability predicts clinical outcome in radiation-treated endometrioid endometrial cancer. Int J Radiat Oncol Biol Phys. 2010;76(1):9–13.
Article
PubMed
PubMed Central
Google Scholar
Wilentz RE, Goggins M, Redston M, et al. Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: a newly described and characterized entity. Am J Pathol. 2000;156(5):1641–51.
Article
CAS
PubMed
PubMed Central
Google Scholar
Humphris JL, Patch AM, Nones K, et al. Hypermutation in pancreatic cancer. Gastroenterology. 2017;152(1):68–74.
Article
CAS
PubMed
Google Scholar
Yamamoto H, Itoh F, Nakamura H, et al. Genetic and clinical features of human pancreatic ductal adenocarcinomas with widespread microsatellite instability. Cancer Res. 2001;61(7):3139–44.
CAS
PubMed
Google Scholar
Genutis LK, Tomsic J, Bundschuh RA, et al. Microsatellite instability occurs in a subset of follicular thyroid cancers. Thyroid. 2019;29(4):523–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
McCabe MJ, Pinese M, Chan CL, et al. Genomic stratification and liquid biopsy in a rare adrenocortical carcinoma (ACC) case, with dual lung metastases. Cold Spring Harb Mol Case Stud. 2019;5(2):a003764.
Article
PubMed
PubMed Central
Google Scholar
Bonneville R, Krook MA, Kautto EA, et al. Landscape of microsatellite instability across 39 cancer types. JCO Precis Oncol. 2017. https://doi.org/10.1200/PO.17.00073.
Article
PubMed
PubMed Central
Google Scholar
Benson AB 3rd, Venook AP, Cederquist L, et al. Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017;15(3):370–98.
Article
CAS
PubMed
Google Scholar
Ruschoff J, Wallinger S, Dietmaier W, et al. Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection. Proc Natl Acad Sci USA. 1998;95(19):11301–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Linnebacher M, Wienck A, Boeck I, et al. Identification of an MSI-H tumor-specific cytotoxic T cell epitope generated by the (-1) frame of U79260(FTO). J Biomed Biotechnol. 2010;2010:841451.
Article
PubMed
PubMed Central
CAS
Google Scholar
Warusavitarne J, Ramanathan P, Kaufman A, et al. 5-fluorouracil (5FU) treatment does not influence invasion and metastasis in microsatellite unstable (MSI-H) colorectal cancer. Int J Colorectal Dis. 2006;21(7):625–31.
Article
PubMed
Google Scholar
Sargent DJ, Marsoni S, Monges G, et al. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol. 2010;28(20):3219–26.
Article
CAS
PubMed
PubMed Central
Google Scholar
Benson AB 3rd, Choti MA, Cohen AM, et al. NCCN practice guidelines for colorectal cancer. Oncology (Williston Park). 2000;14(11A):203–12.
Google Scholar
Kwon Y, Park M, Jang M, et al. Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype. Oncotarget. 2017;8(24):39367–81.
Article
PubMed
PubMed Central
Google Scholar
Diaz LA, Le DT. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med. 2015;373(20):1979.
Article
PubMed
Google Scholar
Yu Y. Molecular classification and precision therapy of cancer: immune checkpoint inhibitors. Front Med. 2018;12(2):229–35.
Article
PubMed
Google Scholar
Eng C, Kim TW, Bendell J, et al. Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial. Lancet Oncol. 2019;20(6):849–61.
Article
CAS
PubMed
Google Scholar
Nivolumab plus Ipilimumab Achieves Responses in dMMR/MSI-H Tumors. Cancer Discov. 2018;8(3):263.
Google Scholar
Tang J, Xu Z, Huang L, et al. Transcriptional regulation in model organisms: recent progress and clinical implications. Open Biol. 2019;9(11):190183.
Article
PubMed
PubMed Central
Google Scholar
Overman MJ, McDermott R, Leach JL, et al. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol. 2017;18(9):1182–91.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wilt C, Le DT. Integrating immunotherapy into colorectal cancer care. Oncology (Williston Park). 2018;32(10):494–8.
Google Scholar
Overman MJ, Lonardi S, Wong KYM, et al. Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair–deficient/microsatellite instability-high metastatic colorectal cancer. J Clin Oncol. 2018;36(8):773–9.
Article
CAS
PubMed
Google Scholar
Tang Z, Li D, Hou S, et al. The cancer exosomes: clinical implications, applications and challenges. Int J Cancer. 2019. https://doi.org/10.1002/ijc.32762.
Article
PubMed
PubMed Central
Google Scholar
O’Neil BH, Wallmark JM, Lorente D, et al. Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma. PLoS ONE. 2017;12(12):e0189848.
Article
PubMed
PubMed Central
CAS
Google Scholar
Innocenti F, Ou F-S, Qu X, et al. Mutational analysis of patients with colorectal cancer in CALGB/SWOG 80405 identifies new roles of microsatellite instability and tumor mutational burden for patient outcome. J Clin Oncol. 2019;37(14):1217–27.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kim ST, Cristescu R, Bass AJ, et al. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer. Nat Med. 2018;24(9):1449–58.
Article
CAS
PubMed
Google Scholar
Choi YY, Kim H, Shin SJ, et al. Microsatellite instability and programmed cell death-ligand 1 Expression in stage II/III gastric cancer: post hoc analysis of the CLASSIC Randomized Controlled Study. Ann Surg. 2019;270(2):309–16.
Article
PubMed
Google Scholar
Novohradsky V, Zajac J, Vrana O, et al. Simultaneous delivery of olaparib and carboplatin in PEGylated liposomes imparts this drug combination hypersensitivity and selectivity for breast tumor cells. Oncotarget. 2018;9(47):28456–73.
Article
PubMed
PubMed Central
Google Scholar
Sun D, Ma J, Wang J, et al. Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer. Cancer Immunol Immunother. 2019;68(9):1527–35.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fader AN, Diaz LA, Armstrong DK, et al. Preliminary results of a phase II study: PD-1 blockade in mismatch repair–deficient, recurrent or persistent endometrial cancer. Gynecol Oncol. 2016;141:206–7.
Article
Google Scholar
Habra MA, Stephen B, Campbell M, et al. Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma. J Immunother Cancer. 2019;7(1):253.
Article
PubMed
PubMed Central
Google Scholar
Chalmers ZR, Connelly CF, Fabrizio D, et al. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med. 2017;9(1):34.
Article
PubMed
PubMed Central
CAS
Google Scholar
Campbell BB, Light N, Fabrizio D, et al. Comprehensive analysis of hypermutation in human cancer. Cell. 2017;171(5):1042–1056.e1010.
Article
CAS
PubMed
PubMed Central
Google Scholar